ARCA biopharma, Inc. (ABIO)

ARCA biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-5.34	-9.93	-19.32	-9.74	-5.48
Depreciation & Amortization	0.11	0.11	0.09	0.09	0.09
Share-Based Compensation	0.69	0.56	0.5	0.04	0.15
Other Operating Activities	-0.47	-1.66	-0.03	1.88	0.44
Operating Cash Flow	-5.01	-10.91	-18.76	-7.73	-4.8
Capital Expenditures	0	-0	-0.04	-0.02	-0
Investing Cash Flow	0	-0	-0.04	-0.02	-0
Share Issuance / Repurchase	0	0	24.07	50.89	7.28
Debt Issued / Paid	0	0	0	-0.41	-0.35
Other Financing Activities	-	-	-0.98	-2.03	-0.37
Financing Cash Flow	0	0	23.09	48.45	6.56
Net Cash Flow	-5.01	-10.91	4.29	40.71	1.76
Free Cash Flow	-5.01	-10.91	-18.81	-7.74	-4.81
Free Cash Flow Per Share	-0.35	-0.76	-1.35	-1.64	-3.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).